Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study

[1]  A. Kasturiratne,et al.  Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study , 2012, BMC Research Notes.

[2]  R. Solá,et al.  Long-term Clinical Course of Decompensated Alcoholic Cirrhosis: A Prospective Study of 165 Patients , 2011, Journal of clinical gastroenterology.

[3]  Han-hsiang Chen,et al.  The dissociation between the diabetes and both Child–Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic , 2011, Hepatology international.

[4]  S. Hagel,et al.  Abnormal Glucose Tolerance: A Predictor Of 30-Day Mortality In Patients With Decompensated Liver Cirrhosis , 2011, Zeitschrift fur Gastroenterologie.

[5]  V. Wong,et al.  Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground , 2011, Journal of gastroenterology and hepatology.

[6]  J. West,et al.  The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study , 2010, Alimentary pharmacology & therapeutics.

[7]  H. Sørensen,et al.  Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study , 2010, Hepatology.

[8]  M. Rodríguez,et al.  Exclusions and deaths on the liver transplant waiting list. , 2010, Transplantation proceedings.

[9]  M. R. Mohideen,et al.  Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka. , 2010, The Ceylon medical journal.

[10]  L. A. Basso,et al.  The conserved Lysine69 residue plays a catalytic role in Mycobacterium tuberculosis shikimate dehydrogenase , 2009, BMC Research Notes.

[11]  N. Toshikuni,et al.  Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus‐related cirrhosis , 2009, Journal of gastroenterology and hepatology.

[12]  H. Nagashima,et al.  Follow-up study of 582 liver cirrhosis patients for 26 years in Japan. , 2008, Liver.

[13]  I. Hickman,et al.  Impact of diabetes on the severity of liver disease. , 2007, The American journal of medicine.

[14]  D. Valla,et al.  Perturbations du métabolisme des glucides au cours de la cirrhose : pathogénie, impact pronostique et implications thérapeutiques , 2007 .

[15]  H. Fukui,et al.  Cryptogenic cirrhosis in the region where obesity is not prevalent. , 2006, World journal of gastroenterology.

[16]  R. Hultcrantz,et al.  Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002 , 2006, Hepatology.

[17]  N. Hayashi,et al.  Oral Glucose Tolerance Test Predicts Prognosis of Patients with Liver Cirrhosis , 2006, The American Journal of Gastroenterology.

[18]  R. Moreau,et al.  Clinical characteristics and outcome of patients with cirrhosis and refractory ascites , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[19]  J. Jahnsen,et al.  Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit , 2004, Scandinavian journal of gastroenterology.

[20]  A. Mihas,et al.  Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. , 2003, Gastroenterology.

[21]  M. Serra,et al.  Effect of Hepatitis C Virus Infection and Abstinence From Alcohol on Survival in Patients With Alcoholic Cirrhosis , 2003, Journal of clinical gastroenterology.

[22]  R. Pandey,et al.  High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India , 2001, International Journal of Obesity.

[23]  P. Thuluvath,et al.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.

[24]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[25]  G. Marchesini,et al.  Prognostic significance of diabetes in patients with cirrhosis , 1994, Hepatology.

[26]  J. Saunders,et al.  A 20-year prospective study of cirrhosis. , 1981, British medical journal.

[27]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[28]  T. Chalmers,et al.  The Natural History of Cirrhosis , 1963 .

[29]  D. García-Compeán,et al.  Hepatogenous diabetes. Current views of an ancient problem. , 2009, Annals of hepatology.

[30]  D. Valla,et al.  [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications]. , 2007, Gastroenterologie clinique et biologique.

[31]  J. Benson,et al.  LIVER FAILURE AND LIVER DISEASE , 2006 .

[32]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[33]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.

[34]  G. Garcia‐Tsao,et al.  Natural history of cirrhosis. , 1968, Lancet.

[35]  W. Stone,et al.  The natural history of cirrhosis. Experience with an unselected group of patients. , 1968, The Quarterly journal of medicine.

[36]  Seah Cheng Siang,et al.  Decompensated cryptogenic and alcoholic CIRRHOSIS IN Singapore. A clinical study of 100 patients. , 1965, Singapore medical journal.